These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 6375562)

  • 41. Cefotaxime and desacetyl cefotaxime kinetics in renal impairment.
    Matzke GR; Abraham PA; Halstenson CE; Keane WF
    Clin Pharmacol Ther; 1985 Jul; 38(1):31-6. PubMed ID: 4006373
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacokinetic-pharmacodynamic evaluation of ceftazidime continuous infusion vs intermittent bolus injection in septicaemic melioidosis.
    Angus BJ; Smith MD; Suputtamongkol Y; Mattie H; Walsh AL; Wuthiekanun V; Chaowagul W; White NJ
    Br J Clin Pharmacol; 2000 Aug; 50(2):184-91. PubMed ID: 10930972
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacokinetics of famciclovir in subjects with varying degrees of renal impairment.
    Boike SC; Pue MA; Freed MI; Audet PR; Fairless A; Ilson BE; Zariffa N; Jorkasky DK
    Clin Pharmacol Ther; 1994 Apr; 55(4):418-26. PubMed ID: 8162668
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Moxalactam pharmacokinetics during hemodialysis.
    Aronoff GR; Sloan RS; Mong SA; Luft FC; Kleit SA
    Antimicrob Agents Chemother; 1981 Apr; 19(4):575-7. PubMed ID: 6454386
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mezlocillin pharmacokinetics after single intravenous doses to patients with varying degrees of renal function.
    Frimodt-Möller N; Maigaard S; Toothaker RD; Bundtzen RW; Brodey MV; Craig WA; Welling PG; Madsen PO
    Antimicrob Agents Chemother; 1980 Apr; 17(4):599-607. PubMed ID: 6446877
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacokinetics of vancomycin in patients with various degrees of renal function.
    Matzke GR; McGory RW; Halstenson CE; Keane WF
    Antimicrob Agents Chemother; 1984 Apr; 25(4):433-7. PubMed ID: 6732213
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Oral flecainide pharmacokinetics in patients with impaired renal function.
    Forland SC; Burgess E; Blair AD; Cutler RE; Kvam DC; Weeks CE; Fox JM; Conard GJ
    J Clin Pharmacol; 1988 Mar; 28(3):259-67. PubMed ID: 3129455
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacokinetics of meropenem in subjects with renal insufficiency.
    Leroy A; Fillastre JP; Etienne I; Borsa-Lebás F; Humbert G
    Eur J Clin Pharmacol; 1992; 42(5):535-8. PubMed ID: 1607000
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacokinetics of cidofovir in renal insufficiency and in continuous ambulatory peritoneal dialysis or high-flux hemodialysis.
    Brody SR; Humphreys MH; Gambertoglio JG; Schoenfeld P; Cundy KC; Aweeka FT
    Clin Pharmacol Ther; 1999 Jan; 65(1):21-8. PubMed ID: 9951427
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacokinetics of ceftazidime in male and female volunteers.
    Sommers DK; Walters L; Van Wyk M; Harding SM; Paton AM; Ayrton J
    Antimicrob Agents Chemother; 1983 Jun; 23(6):892-6. PubMed ID: 6351732
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacokinetics, intramuscular bioavailability and tissue residue profiles of ceftazidime in a rabbit model.
    Abd El-Aty AM; Goudah A; Abo El Sooud K
    Dtsch Tierarztl Wochenschr; 2001 Apr; 108(4):168-71. PubMed ID: 11370478
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacokinetics of intravenous ciprofloxacin in normal and renally impaired subjects.
    Shah A; Lettieri J; Blum R; Millikin S; Sica D; Heller AH
    J Antimicrob Chemother; 1996 Jul; 38(1):103-16. PubMed ID: 8858462
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Pharmacokinetics of cefotaxime in patients with chronic renal impairment (author's transl)].
    Fillastre JP; Ings RM; Leroy A; Humbert G; Godin M
    Nouv Presse Med; 1981 Feb; 10(8):574-9. PubMed ID: 6259595
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacokinetics of ceftazidime in febrile neutropenic patients.
    Nyhlén A; Ljungberg B; Nilsson-Ehle I
    Scand J Infect Dis; 2001; 33(3):222-6. PubMed ID: 11303815
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cefamandole kinetics in uremic patients undergoing hemodialysis.
    Gambertoglio JG; Aziz NS; Lin ET; Grausz H; Naughton JL; Benet LZ
    Clin Pharmacol Ther; 1979 Nov; 26(5):592-9. PubMed ID: 498702
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacokinetics of cefazolin, a new cephalosporin antibiotic, in normal and uraemic patients.
    Leroy A; Canonne MA; Fillastre JP; Humbert G
    Curr Ther Res Clin Exp; 1974 Sep; 16(9):878-89. PubMed ID: 4214662
    [No Abstract]   [Full Text] [Related]  

  • 57. Pharmacokinetics and dose proportionality of cefpimizole in normal humans after intramuscular administration.
    Lakings DB; Novak E; Friis JM; Lunan CM; Paxton LM
    Antimicrob Agents Chemother; 1986 Feb; 29(2):271-7. PubMed ID: 3717932
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacokinetics of cefotaxime.
    Fu KP; Aswapokee P; Ho I; Matthijssen C; Neu HC
    Antimicrob Agents Chemother; 1979 Nov; 16(5):592-7. PubMed ID: 526000
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Disposition of minoxidil in patients with various degrees of renal function.
    Halstenson CE; Opsahl JA; Wright CE; Fleishaker JC; Andreadis NA; Sobieraj J; Matzke GR
    J Clin Pharmacol; 1989 Sep; 29(9):798-802. PubMed ID: 2808745
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Single-Center Evaluation of the Pharmacokinetics of WCK 5222 (Cefepime-Zidebactam Combination) in Subjects with Renal Impairment.
    Preston RA; Mamikonyan G; DeGraff S; Chiou J; Kemper CJ; Xu A; Mastim M; Yeole R; Chavan R; Patel A; Friedland HD; Bhatia A
    Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30397067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.